Verily Launches Landmark Partnership With CU Anschutz And UCHealth
Key Takeaways
- Verily is partnering with CU Anschutz and UCHealth to create an AI-enabled ecosystem for biomedical research.
- The partnership will utilize Verily Workbench to analyze vast, multimodal biomedical datasets, focusing on areas like oncology and transplant medicine.
- The goal is to generate actionable insights for discovering new drug targets, improving drug delivery, and optimizing clinical trials.
- The collaboration aims to address the critical healthcare challenge of data interoperability, which hinders insight generation.
- Initial results show significant efficiency gains, including 95% accuracy and 30x faster data extraction than manual processes.
Precision health giant Verily has announced a significant partnership with CU Anschutz and UCHealth to establish an AI-enabled ecosystem focused on generating insights from vast datasets. This collaboration aims to build curated AI models across various therapeutic areas, including oncology and transplant medicine, using CU Anschutzâs research data through Verily Workbench, a secure environment for multimodal data analytics. A joint venture named RefinedScience will leverage this technology to integrate multiomic datasets to produce actionable insights for discovering new drug targets and optimizing clinical trials. Kimberly Muller of CU Anschutz emphasized the goal of data-driven transformation supported by a sustainable infrastructure, while Verily's Dr. Erich Huang highlighted the critical need for interoperability across healthcare datasets. The partnership has already demonstrated success, achieving over 95% accuracy and 30x faster data extraction compared to manual methods, underscoring the potential of combining strong data resources with mature AI platforms.
